Status:
COMPLETED
A Retrospective Study Evaluating the Use of Permacol Surgical Implant in the Repair of Abdominal Wall Defects
Lead Sponsor:
Medtronic - MITG
Conditions:
Abdominal Wall Defects
Eligibility:
All Genders
18+ years
Brief Summary
To evaluate short, mid and long term clinical outcomes associated with the use of Permacol in the treatment of abdominal wall defects.
Eligibility Criteria
Inclusion
- Equal or over 18 years of age
- Had undergone surgical repair or reconstruction of abdominal wall defects, ventral hernias or incisional hernias using Permacol Surgical Implant.
- At least 12 months of follow-up post date of surgery (-30 days)
- Undergone open or laparoscopic repairs
Exclusion
- Had undergone inguinal, parastomal, diaphragmatic or paraesophageal/hiatal hernia repair
- Any prior use of Permacol in abdominal wall repair
Key Trial Info
Start Date :
October 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2012
Estimated Enrollment :
343 Patients enrolled
Trial Details
Trial ID
NCT01214252
Start Date
October 1 2010
End Date
January 1 2012
Last Update
May 9 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Annie Choi
Bedford, Massachusetts, United States, 01730